Omalizumab biosimilar (Reliance Life Sciences)
奥马珠单抗生物类似药（Reliance Life Sciences）
Report date: 2025/03/07 17:33:35
Base Information
Drug NameOmalizumab biosimilar (Reliance Life Sciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A
Develop Information
Active CompaniesReliance Life Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A